Elevai Labs Inc

ELEVAI Labs (NASDAQ: ELAB) was founded by Dr. Jordan Plews, a Stanford-trained scientist, and Dr. Tim Sayed, a Harvard-trained plastic surgeon. The company was created to solve unmet needs in the regenerative aesthetics skincare space and provide the medical-dispensed skincare market with best-in-class exosome technology. Together they developed the proprietary, ethically sourced, human umbilical mesenchymal stem cell (hUMSC) exosome technology, ELEVAI Exosomes™. Dr. Plews has a background in biochemical engineering and stem cell research. His cumulative years in the field and in academics have informed the innovative technology, formulations, ingredient selection, and vertically integrated lab — all elements which are essential to ELEVAI’s efficacious and science-driven skin care product line. The ELEVAI E-Series™ products, empower and enfinity, were developed to provide both post-treatment support and ongoing daily aftercare. Both products contain exosomes; ultra-small, nanoparticle compartments packed with growth factors known to support skin health. The patent-pending ELEVAI Exosome™ is the powerhouse ingredient in all ELEVAI products and mimics the elegant repair process of nature along with a selection of high-quality actives to provide regenerative skin health for any skin type.@ElevaiSkincare.com